Cargando…
Optimization and biological validation of an in vitro assay using the transfected Dm28c/pLacZ Trypanosoma cruzi strain
There is an urgent need to develop safer and more effective drugs for Chagas disease, as the current treatment relies on benznidazole (BZ) and nifurtimox (NFX). Using the Trypanosoma cruzi Dm28c strain genetically engineered to express the Escherichia coli β-galactosidase gene, lacZ, we have adapted...
Autores principales: | Gulin, Julián Ernesto Nicolás, Rocco, Daniela Marisa, Alonso, Victoria, Cribb, Pamela, Altcheh, Jaime, García-Bournissen, Facundo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355463/ https://www.ncbi.nlm.nih.gov/pubmed/34386588 http://dx.doi.org/10.1093/biomethods/bpab004 |
Ejemplares similares
-
Miltefosine and Benznidazole Combination Improve Anti-Trypanosoma cruzi In Vitro and In Vivo Efficacy
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2022) -
Refining drug administration in a murine model of acute infection with Trypanosoma cruzi
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2020) -
Trypanosoma cruzi Clone Dm28c Draft Genome Sequence
por: Grisard, Edmundo Carlos, et al.
Publicado: (2014) -
Secretome analysis of Trypanosoma cruzi by proteomics studies
por: Brossas, Jean-Yves, et al.
Publicado: (2017) -
Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review
por: Gulin, Julián Ernesto Nicolás, et al.
Publicado: (2015)